Bradley Pharmaceuticals, Inc., recently announced the launch of its authorized generic version for ADOXA® 150 mg strength doxycycline monohydrate tablets. ...
... Inc. (NYSE: BDY) today announced the launch of its authorized generic version for ADOXA(R) 150 mg strength doxycycline monohydrate tablets. ...
... PM Bradley Pharmaceuticals Inc. (BDY) announced the launch of its authorized generic version for ADOXA 150 mg strength doxycycline monohydrate tablets. ...
Bradley Pharmaceuticals Inc. (NYSE: BDY) said Tuesday that it has launched 150 mg strength doxycycline monohydrate tablets, a generic version of Adoxa, ...